4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-17-032090
Director sold 16,926 shares at an average $54.19 ($917,279)
- Director acquired 16,926 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FOOTE SUSAN BARTLETT · Director
Table I: Non-derivative
30 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-10 | Exercise or conversion : show line 1 in the form | +6,573 | $45.45 | $298,743 | 27,313 | D |
| 2017-11-10 | Sale : show line 2 in the form | −290 | $54.06 | $15,677 | 27,023 | D |
| 2017-11-10 | Sale : show line 3 in the form | −200 | $54.07 | $10,814 | 26,823 | D |
| 2017-11-10 | Sale : show line 4 in the form | −400 | $54.09 | $21,636 | 26,423 | D |
| 2017-11-10 | Sale : show line 5 in the form | −510 | $54.10 | $27,591 | 25,913 | D |
| 2017-11-10 | Sale : show line 6 in the form | −1,200 | $54.11 | $64,932 | 24,713 | D |
| 2017-11-10 | Sale : show line 7 in the form | −600 | $54.12 | $32,472 | 24,113 | D |
| 2017-11-10 | Sale : show line 8 in the form | −600 | $54.13 | $32,478 | 23,513 | D |
| Open-market sales · 16,926 sh · avg $54.19 · $917,279 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-10 | Exercise or conversion : show line 31 in the form Non-qualified Stock Option (Right to Buy) | −6,573 | 0 | D |
| 2017-11-10 | Exercise or conversion : show line 32 in the form Non-qualified Stock Option (Right to Buy) | −10,353 | 0 | D |
Loading xslF345X03/form4.xml…